Auto-injectors Market, by Product Type, by Disease Indication (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Others ), by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022

Description

Auto- injector is a medical device which can deliver dose of medications. Auto injectors are easy to use and self-administration by patients is possible. Auto-injectors are disposable and there is a tremendous growth in the development of reusable auto-injectors with multiple dosing. Auto-injectors come under injectable drug delivery which is considered as the most effective route of administration for the effective delivery of drugs to the targeted site, which enhances the patient's compliance to the drug. The Injectable delivery enhances the rapid absorption of drug from various sites such as subcutaneous, intravenous, and intramuscular. The injectable delivery increases the bioavailability of the drug at the systemic circulation, which offers availability of drug at intended site of action. Epinephrine auto-injector is a type of auto-injector widely used for people at risk of anaphylaxis. Auto-injectors enclose prefilled syringes or cartridges which are driven by a spring system. Auto-injectors are often used in the military to protect personnel from chemical warfare agents.

Market Dynamics

Adoption of inorganic growth strategies such as product launch by key market players is expected to drive the global auto-injectors market over the forecast period. For instance, in April 2020, Teva Pharmaceutical Industries Ltd., a pharmaceutical company, announced that they had launched auto-injector for AJOVY, which is indicated for the preventive treatment of migraine in adults. This new auto-injector has several features such as easy handling including a button-free, push-down mechanism, audible cues that signal progress of administration, and a window that displays when the dose has been delivered.

Key features of the study:

This report provides an in-depth analysis of the global auto-injectors market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global auto-injectors market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Becton, Dickinson and Company, Sanofi S.A., Takeda Pharmaceutical Company Limited, Xeris Biopharma Holdings Inc., BlackHagen Design, GSK plc., Genentech, Inc., AstraZeneca, Owen Mumford Ltd., Stevanato Group, Jabil Inc., Pfizer, Inc., Mylan N.V., Novartis AG, Bayer AG, Janssen Pharmaceuticals, Inc., Antares Pharma, Eli Lilly and Company, Amgen Inc., Rafa Laboratories Ltd., Halozyme, Inc., Biogen, and Teva Pharmaceutical Industries Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global auto-injectors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global auto-injectors market

Detailed Segmentation:

Global Auto-injectors Market, By Product Type:
- Prefilled Auto-injectors
- Fillable Auto-injectors
Global Auto-injectors Market, By Disease Indication:
- Anaphylaxis
- Multiple Sclerosis
- Rheumatoid Arthritis
- Others (Diabetes, Psoriasis, etc.)
Global Auto-injectors Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Auto-injectors Market, By Region:
- North America
  - By Country
- U.S.
- Canada
- Latin America
  - By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Region/Country
- South Africa
- Central Africa
- North Africa
Company Profiles
- Becton, Dickinson and Company*
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Sanofi S.A.
- Takeda Pharmaceutical Company Limited
- Xeris Biopharma Holdings Inc.
- BlackHagen Design
- GSK plc.
- Genentech, Inc.
- AstraZeneca
- Owen Mumford Ltd.
- Stevanato Group
- Jabil Inc.
- Pfizer, Inc.
- Mylan N.V.
- Novartis AG
- Bayer AG
- Janssen Pharmaceuticals, Inc.
- Antares Pharma
- Eli Lilly and Company
- Amgen, Inc.
- Rafa Laboratories Ltd.
- Halozyme, Inc.
- Biogen
- Teva Pharmaceutical Industries Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI1035

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Disease Indication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
Regulatory Scenario
PEST Analysis

4. Global Auto-injectors Market- Impact of Coronavirus (Covid-19) Pandemic

Overall Impact
Impact on Supply and Demand
COVID-19 Impact on the market

5. Global Auto-injectors Market, By Product Type, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Prefilled Auto-injectors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Fillable Auto-injectors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Auto-injectors Market, By Disease Indication, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Anaphylaxis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Multiple Sclerosis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Rheumatoid Arthritis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Others (Diabetes, Psoriasis, etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Auto-injectors Market, By Distribution Channel, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Auto-injectors Market, By Region, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sanofi S.A.
Takeda Pharmaceutical Company Limited
Xeris Biopharma Holdings Inc.
BlackHagen Design
GSK plc.
Genentech, Inc.
Owen Mumford Ltd.
Stevanato Group
Jabil Inc.
Pfizer, Inc.
Mylan N.V.
Novartis AG
Bayer AG
Janssen Pharmaceuticals, Inc.
Antares Pharma
Eli Lilly and Company
Amgen, Inc.
Rafa Laboratories Ltd.
Halozyme, Inc.
Biogen
Teva Pharmaceutical Industries Ltd.

10. Section

Research Methodology
About Us

Auto-injectors Market, by Product Type, by Disease Indication (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Others ), by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030